Is Recombinant Human Erythropoietin Treatment in Myelodysplastic Syndromes Worthwhile?

M. A. Aloe Spiriti Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

M. C. Petti Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

R. Latagliata Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

G. Avvisati Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

C. De Gregoris Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

S. Proia Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

P. Fazi Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

G. Jaalouk Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

M. Mancini Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

A. Spadea Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

R. Villa Haematology, Department of Human Biopathology, Cilag Spa, Medical Direction Milano, Italy

F. Mandelli Haematology, Department of Human Biopathology, University “La Sapienza” of Rome, Italy

Articles from other publishers (12)